busulfan has been researched along with Lymphoma, Large-Cell, Anaplastic in 3 studies
Lymphoma, Large-Cell, Anaplastic: A systemic, large-cell, non-Hodgkin, malignant lymphoma characterized by cells with pleomorphic appearance and expressing the CD30 ANTIGEN. These so-called hallmark cells have lobulated and indented nuclei. This lymphoma is often mistaken for metastatic carcinoma and MALIGNANT HISTIOCYTOSIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukano, R | 1 |
| Mori, T | 1 |
| Fujita, N | 1 |
| Kobayashi, R | 1 |
| Mitsui, T | 1 |
| Kato, K | 1 |
| Suzuki, R | 1 |
| Suzumiya, J | 1 |
| Fukuda, T | 1 |
| Shindo, M | 1 |
| Maseki, N | 1 |
| Shimoyama, T | 1 |
| Okada, K | 1 |
| Inoue, M | 1 |
| Inagaki, J | 1 |
| Hashii, Y | 1 |
| Sato, A | 1 |
| Tabuchi, K | 1 |
| Ahn, JS | 1 |
| Yang, DH | 1 |
| Jung, SH | 1 |
| Chae, YS | 1 |
| Sohn, SK | 1 |
| Yhim, HY | 1 |
| Kwak, JY | 1 |
| Lee, SR | 1 |
| Kim, YK | 1 |
| Kim, HJ | 1 |
| Lee, JJ | 1 |
| Nagler, A | 1 |
| Aker, M | 1 |
| Or, R | 1 |
| Naparstek, E | 1 |
| Varadi, G | 1 |
| Brautbar, C | 1 |
| Slavin, S | 1 |
3 other studies available for busulfan and Lymphoma, Large-Cell, Anaplastic
| Article | Year |
|---|---|
Successful outcome with reduced-intensity condition regimen followed by allogeneic hematopoietic stem cell transplantation for relapsed or refractory anaplastic large-cell lymphoma.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Busulfan; Child; Female; Hematopoietic Stem Ce | 2019 |
Autologous stem cell transplantation with busulfan, cyclophosphamide, and etoposide as an intensifying frontline treatment in patients with peripheral T cell lymphomas: a multicenter retrospective trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Combined Modality Thera | 2013 |
Low-intensity conditioning is sufficient to ensure engraftment in matched unrelated bone marrow transplantation.
Topics: Adolescent; Adult; Antilymphocyte Serum; Bone Marrow Transplantation; Busulfan; Cell Count; Child; C | 2001 |